Published in BMJ on April 18, 1998
New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA (1962) 6.21
Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation (1991) 2.87
Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. Am J Cardiol (1976) 1.23
Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol (1979) 1.07
Does cardioversion of atrial fibrillation result in myocardial damage? Br Med J (Clin Res Ed) (1988) 0.92
Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol (1999) 3.44
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol (2001) 2.67
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost (2006) 2.08
Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol (2000) 1.76
Deferred consent in emergency intensive care research: what if the patient dies early? Use the data or not? Intensive Care Med (2007) 1.76
Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J Virol (1991) 1.72
Optical dysfunction of the crystalline lens in aquaporin-0-deficient mice. Physiol Genomics (2001) 1.59
Bacteremia following operative endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.43
Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Wien Klin Wochenschr (2000) 1.42
Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol (2012) 1.40
Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J (2001) 1.21
Signaling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol (1998) 1.15
Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol (1993) 1.13
Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol (2001) 1.12
Absorption and bioavailability of nebulized morphine. Br J Anaesth (1988) 1.09
Effect of inhibitors of Na+/H+-exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes. Br J Pharmacol (1998) 1.09
B lymphocyte-derived IL-16 attracts dendritic cells and Th cells. J Immunol (2000) 1.07
Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol (1997) 1.07
Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood (2001) 1.05
Imported malaria: six cases of severe Plasmodium falciparum infection in Innsbruck, Austria, within a period of five weeks (February/March 1999) Wien Klin Wochenschr (2000) 1.05
Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis (2002) 1.04
A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol (1999) 1.04
Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol (1997) 1.03
Robotic totally endoscopic coronary artery bypass: program development and learning curve issues. J Thorac Cardiovasc Surg (2004) 1.02
Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation (2001) 1.01
Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis (2009) 0.99
RANTES chemokine expression in diseased and normal human tissues. Cytokine (1996) 0.97
Differences in reutilization of thymidine in hemopoietic and lymphopoietic tissues of the normal mouse. Cell Tissue Kinet (1973) 0.97
Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol (2003) 0.96
Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol (1996) 0.96
Giant liposarcoma of the esophagus: radiological findings. J Thorac Imaging (1999) 0.95
Direct correlation of parvalbumin levels with myosin isoforms and succinate dehydrogenase activity on frozen sections of rodent muscle. J Histochem Cytochem (1991) 0.94
Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin. Atherosclerosis (2001) 0.93
LST1: a gene with extensive alternative splicing and immunomodulatory function. J Immunol (2000) 0.92
Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res (1997) 0.92
Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease. Hepatology (1993) 0.92
Phonosurgery of the vocal folds: a classification proposal. Eur Arch Otorhinolaryngol (2002) 0.92
Technical challenges in totally endoscopic robotic coronary artery bypass grafting. J Thorac Cardiovasc Surg (2006) 0.91
Septicaemia and endomyocarditis caused by Aerococcus urinae. Wien Klin Wochenschr (1999) 0.90
Theoretical basis for the activity of thalidomide. BioDrugs (2001) 0.90
CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int J Immunopathol Pharmacol (2003) 0.90
Induction of endothelial cell differentiation into capillary-like structures by substance P. Eur J Pharmacol (1996) 0.90
Exudative lesions of Reinke's space: a terminology proposal. Eur Arch Otorhinolaryngol (2008) 0.89
Incidence and clinical relevance of herniation of the mylohyoid muscle with penetration of the sublingual gland. Eur Arch Otorhinolaryngol (2007) 0.89
Reutilization of 5- 125 I-iodo-2'-deoxyuridine and 3 H-thymidine in regenerating liver of mice. Proc Soc Exp Biol Med (1971) 0.88
High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. Minerva Anestesiol (2013) 0.88
Biochemical and functional properties of large and small dense-core vesicles in sympathetic nerves of rat and ox vas deferens. Neuroscience (1984) 0.88
Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen. Peptides (1991) 0.87
Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun (2001) 0.87
Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am Rev Respir Dis (1988) 0.87
Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiol (1993) 0.86
Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol (1996) 0.86
Atrial natriuretic factor (ANF) after laparoscopy and morphine application for pain therapy. Clin Exp Obstet Gynecol (2000) 0.85
Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol (1997) 0.85
Hyperplastic epithelial lesions of the vocal folds: combined use of exfoliative cytology and laryngostroboscopy in differential diagnosis. Eur Arch Otorhinolaryngol (2007) 0.85
Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul Pept (1992) 0.84
The influence of beta blockers on cardiovascular reactivity and Type A behavior pattern in hypertensives. Psychosom Med (1983) 0.84
Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation. J Lipid Res (1997) 0.84
Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2001) 0.84
Functional expression of chemokine receptor 2 by normal human eosinophils. J Allergy Clin Immunol (2001) 0.84
Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood (1998) 0.83
Serum parvalbumin, an indicator of muscle disease in murine dystrophy and myotonia. Muscle Nerve (1990) 0.83
Dendritic cell migration in different micropore filter assays. Immunol Lett (2000) 0.83
Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett (1993) 0.83
Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital. J Prev Med Hyg (2009) 0.83
Human chorionic gonadotrophin: a chemoattractant for human blood monocytes, neutrophils and lymphocytes. J Endocrinol (1994) 0.82
Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol (1993) 0.82
Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with beta-endorphin. Brain Behav Immun (1994) 0.82
Excretion of tiapamil in breast milk. Br J Clin Pharmacol (1988) 0.82
Substance P receptor-mediated secretion of respiratory glycoconjugate from feline airways in vitro. Exp Lung Res (1989) 0.82
Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils. Cardiovasc Res (1998) 0.82
Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro. Immunol Lett (1997) 0.82
Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine- and endotoxin-activated endothelium. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.82
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. Eur Arch Otorhinolaryngol (2013) 0.81
Plasma catecholamines in arterial and capillary blood. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.81
The role of immune activation in endotoxin-induced atherogenesis. J Endotoxin Res (2001) 0.81
The acute-phase protein alpha 1-antitrypsin inhibits transferrin-receptor binding and proliferation of human skin fibroblasts. Biochim Biophys Acta (1998) 0.81
Bombesin in human and guinea pig alveolar macrophages. J Immunol (1986) 0.81
Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation (2001) 0.81
Sudden death in a young competitive athlete with Wolff-Parkinson-White syndrome. Eur Heart J (1987) 0.81
Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chim Acta (1997) 0.81
Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitro. Immunol Lett (1992) 0.81
Single coronary artery bypass grafting--a comparison between minimally invasive 'off pump' techniques and conventional procedures. Eur J Cardiothorac Surg (1998) 0.81
Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagul Fibrinolysis (2001) 0.81
Syphilis is back: presentation of three cases at the ENT department. B-ENT (2012) 0.81
[Pancreatopathy in diabetes mellitus]. Zentralbl Allg Pathol (1986) 0.80
Chromatographic analysis of gastrin-releasing peptide in heat-inactivated fetal calf serum. Cell Tissue Kinet (1986) 0.80
Signal transduction pathways in directed migration of human monocytes induced by human growth hormone in vitro. Int Immunopharmacol (2001) 0.80
Syndecan-4-dependent migration of human eosinophils. Clin Exp Allergy (2004) 0.80
Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro. Arterioscler Thromb Vasc Biol (1997) 0.80
Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction. Am Heart J (1992) 0.80